Lisa French
CIK 1948055 · EVP & Chief Commercial Officer · last filed 2026-02-26
Lisa French is an EVP & Chief Commercial Officer who has filed 11 SEC Form 4 insider transactions across 1 company since 2022.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
11
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Keenova Therapeutics plc (MNK) Delisted | EVP & Chief Commercial Officer | 75,091 | $0.34 | $25.5K | $0 | 3 | 2023-07-05 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-26 | — | Grant (A) | — | $0 | |
| 2026-01-05 | — | Mixed | +4,590 | $0 | |
| 2025-08-04 | — | Grant (A) | — | $0 | |
| 2025-01-17 | — | Tax (F) | −1,670 | $0 | |
| 2025-01-02 | — | Mixed | +3,824 | $0 | |
| 2024-02-06 | — | Grant (A) | — | $0 | |
| 2023-11-16 | — | Disp (D) | −64,455 | $0 | |
| 2023-10-02 | — | Tax (F) | −10,636 | -$904 | |
| 2023-07-05 | Keenova Therapeutics plc (MNK) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-04-05 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | — | $0 | EDGAR |